Chapter 11. Women's Health
1. CDC. 2004. Complementary & Alternative Medicine Use Among Adults: United States, 2002. Advance Data. Issue 343.
2. Astin J. 1998. Why patients use alternative medicine: Results of national study. JAMA. Vol 279, No. 1947-1953
3. Grady D. Management of menopausal symptoms. N Engl J Med 2006;355:2338-47
4. American College of Obstetricians and Gynecologists (ACOG). Educational Bulletin No. 247. Hormone Replacement Therapy. Washington, DC:ACOG, 1998.
5. Woods NF, Mitchell ES. Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women’s lives. Am J Med. 2005;118:14S-24S
6. Freeman EW, et al. Symptom Reports from a cohort of African American and white women in the late reproductive years. Menopause. 2001;8:33-42.
7. Haimov-Kochman R; Hochner-Celnikier D. Hot flashes revisited: pharmacological and herbal options for hot flashes management. What does the evidence tell us? Acta Obstet Gynecolo Scand Oct 2005;84(10):972-9
8. Ettinger B, Pressman A, Bradley C. Comparison of continuation of postmenopausal hormone therapy: transdermal versus oral estrogen. Menopause 1998;5:152-156
9. Her AL, Stefanik M, Stafford RS. National use of postmenopausal hormone therapy. JAMA. 2004;291:47-53.
10. Newton KM, et al. Use of alternative therapies for menopause symptoms: results of a population-based survey. Obstet Gynecol July 2002;100:18-25.
11. Van Patten CL, Olivotto IA, Chambers GK, et al. Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial. J Clin Oncol. 2002;20:1449-1455
12. Nedrow A, et al. Complementary and alternatives therapies for the management of menopause-related symptoms. A systematic evidence review. Arch Intern med. 2006;166:1453-1465
13. Krebs EE, et al. Phytoestrogens for treatment of menopausal symptoms: a systematic review. Obstet Gynecol. 2004;104:824-836
14. Penotti M, et al. Effect of soy-derived isoflavones on hot flushes, endometrial thickness and the pulsatility index of the uterine and cerebral arteries. Fertil Ster 2003;79:1112-17
15. Lethaby AE, Brown J, Marjoribanks J, Kronenberg F, Roberts H, Eden J. Phytoestrogens for vasomotor menopausal symptoms. Cochrane Database of Systematic Reviews 2007, issue 4. Art. No.: CD001395. DOI: 10.1002/14651858.CD001395.pub3.
16. Tice JA, et al: Phytoestrogen supplements for the treatment of hot flashes: the isoflavone clover extract (ICE) study: A randomized controlled trial. JAMA 2003;290:207-214.
17. Atkinson C, et al: Red-clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo controlled trial. Breast Cancer Res. 2004;6:R170-R179
18. Baber RJ, et al: Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric. 1999;2:79-84
19. Stoll W. Phytopharmacon influences atrophic vaginal epithelium: Double-blind study, Cimicifuga vs. estrogenic substances. Therapeutikon. 1987;1:23-32
20. Lehman-Willenbrock W, Riedel HH: Clinical and endocrinologic examinations concerning therapy of climacteric symptoms following hysterectomy with remaining ovaries. Zent BL Gynakol. 1998;110:611-618.
21. Skidmore-Roth L. Mosby’s Handbook of Herbs and Natural Supplements – third Edition. St. Louis, MO, Elsevier Mosby, 2006:137-141
22. National Center for Complementary and Alternative Medicine: Workshop on the safety of black cohosh in clinical studies. Accessed January 27, 2008. nccam.nih.gov/news/pastmeetings/blackcohosh_mtngsumm.pdf#summary
23. Carroll DG. Nonhormonal therapies for hot flashes in menopause. Am Fam Physician. 2006;73:457-464
24. Daley A, Stokes-Lampard H, Mutrie N, MacArthur C. Exercise for vasomotor menopausal symptoms. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.:CD006108. DOI:10.102/14651858.CD006108.pub2.
25. Ivarsson T, Spetz AC, Hammar M. Physical exercise and vasomotor symptoms in postmenopausal women. Maturitas 1998;29:139-46.
26. Stadberg E, Mattsson LA, Milsom I. Factors associated with climacteric symptoms and the use of hormone replacement therapy. Acta Obstet Gynecol Scand 2000;79:286-92
27. Freedman RR, Woodward S. Behavioral treatment of menopausal hot flushes: evaluation by ambulatory monitoring. Am J Obstet Gynecol. 1992;167:436-9
28. Freedman RR, et al. biochemical and thermoregulatory effects of behavioral treatment for menopausal hot flashes. Menopause. 1995;2:211-8
29. Rakel D. Menopause. Integrative Medicine – Second Edition. Philadelphia, PA, Saunders Elsevier, 2007;54:589-600
30. Cleary C, Fox JP. Menopausal symptoms: an osteopathic investigation. Complement Ther Med. 1994;2:181-186
31. Carpenter JS, Andrykowski MA: Menopausal symptoms in breast cancer survivors. Oncol Nurs forum 26:1311-1317, 1999.
32. Williamson J, et al: Randomised controlled trial of reflexology for menopausal symptoms. BJOG 109:1050-1055, 2002.
33. Sandberg m, et al. Effects of elector-acupuncture on psychological distress in postmenopausal women. Complement Ther Med. 2002;10:161-169
34. Wyon Y, et al. A comparison of acupuncture and estradiol treatment of vasomotor symptoms in postmenopausal women. Climacteric. 2004;7:153-164
35. Wyon Y, et al. Effects of acupuncture on climacteric vasomotor symptoms, quality of life, and urinary excretion of neuropeptides among postmenopausal women. Menopause. 1995;2:3-12
36. Cohen SM, Rousseau ME, Carey BL. Can acupuncture ease the symptoms of menopause? Holist Nurs Pract. 2003;17:295-299
37. Wiklund I, et al. Effects of a standardized ginseng extract on quality of life and physiological parameters in symptomatic postmenopausal women: a double-blind, placebo-controlled trial. Swedish Alternative Medicine Group. Int J Clin Pharmacol Res 1999;19:89-99
38. Mortola JF. A risk-benefit appraisal of drugs used in the management of premenstrual syndrome. Drug Saf. 1994;10:160-9
39. Wyatt K, Dimmock PW, O’Brien PM. Premenstrual syndrome. In: Barton S, ed. Clinical evidence. 4th issue. London: BMJ Publishing Group, 2000:1121-33
40. Daugherety JE. Treatment strategies for premenstrual syndrome. Am Fam Physician 1998;58:183-92, 197-8
41. Moline ML, Zendell SM. Evaluating and managing premenstrual syndrome. Medscape Women Health 2000;5:1-6
42. Dickerson LM, Mazyck PJ, Hunter MH. Premenstrual syndrome. Am Fam Physician 2003;67:1743-1752
43. ACOG Practice Bulletin. Clinical management guidelines for Obstetrian-Gynecologists. Number 15, April 2000. Premenstrual syndrome. Obstet Gynecol 2000;95:1-9.
44. Moline ML, Zendell SM. Evaluating and Managing Premenstrual Syndrome. Medscape General Medicine 2000;2(2)
45. Rakel D. Premenstrual Syndrome. Integrative Medicine – Second Edition. Philadelphia, PA, Saunders Elsevier, 2007;55:601-611.
46. Meier B, et al. Pharmacological activities of vitex agnus-castus extracts in vitro. Phytomedicine 2000;7:373-81.
47. Jarry H, et al. In vitro prolactin but not LH and FSH release is inhibited by compounds in extracts of Agnus castus: direct evidence for a dopaminergic principle by the dopamine receptor assay. Exp Clin Endocrinol 1994;102:448-54.
48. Wuttke W. Dopaminergic action of extracts of Agnus castus. Forschende Komplementarmedizen 1996;3:329-30
49. Schellenberg R. Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised placebo controlled study. BMJ 2001;322:134-7
50. Wuttke W, et al. Treatment of cyclical mastalgia: results of a randomized, placebo controlled, double-blind study. Geburtshilfe Frauenheilkd 1997;57:569-74
51. Petters-Welter C, Albrecht M. Menstrual abnormalities and PMS. Vitex agnus-castus in a study of application. Therapiewoche Gynakol 1994;7:49-52
52. Dittmar F, et al. Premenstrual syndrome: treatment with a phytopharmaceutical. Therapiewoche Gynakol 1992;5:60-8
53. Loch EG, Selle H, Boblitz N. Treatment of premenstrual syndrome with a phytopharmaceutical formulation containing Vitex agnus castus. J Womens Health Gend Based Med 2000;9:315-20
54. Lauritzen C, et al. Treatment of premenstrual tension syndrome with vitex agnus castus. Controlled, double-blind study versus pyridoxine. Phytomedicine 1997;4:183-9
55. Turner S, Mills S. A double-blind clinical trial on a herbal remedy for premenstrual syndrome: a case study. Complement Ther Med 1993;1:73-7
56. Halaska M, et al. Treatment of cyclical mastodynia using an extract of Vitex agnus castus: results of a double-blind comparison with a placebo. Ceska Gynekol 1998;63:388-92
57. Skidmore-Roth L. Mosby’s Handbook of Herbs and Natural Supplements – third Edition. St. Louis, MO, Elsevier Mosby, 2006:272-6
58. Dittmar FW, et al. Premenstrual syndrome. Treatment with a phytopharmaceutical. Therapiewoche Gynakol 1992;5:60-8
59. Girman A, Lee R, Kligler B. An integrative medicine approach to premenstrual syndrome. Clin J Women’s Health 2002;2:116-27
60. Blumenthal M, et al. The Complete German commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin: American botanical council and Boston: Integrative Medicine communications, 1998: 90.
61. Tamborini A, Taurelle R. Value of standardized Ginkgo biloba extract (EGb761) in the management of congestive symptoms of premenstrual syndrome. Rev Fr Gynecol Obstet 1993;88:447-57
62. Skidmore-Roth L. Mosby’s Handbook of Herbs and Natural Supplements – third Edition. St. Louis, MO, Elsevier Mosby, 2006:487-92
63. Budieri D, Li Wan Po A, Dornan JC: Is evening primrose oil of value in the treatment of premenstrual syndrome? Control Clin Trials 1996;17:60-8.
64. Collins A, et al. Essential acids in the treatment of premenstrual syndrome. Obstet Gynec 1993;81:93-8
65. Khoo SK, Munroe C, Battistutta D. Evening primrose and the treatment of premenstrual syndrome. Med J Austr 1990;153:189-90
66. Hardy ML. Women’s Health Series: Herbs of Special Interest to Women. J Am Pharm Assoc 2000;40(2):23-42
67. Skidmore-Roth L. Mosby’s Handbook of Herbs and Natural Supplements – third Edition. St. Louis, MO, Elsevier Mosby, 2006:422-5
68. Prior JC, et al. conditioning exercise decreases premenstrual symptoms: a prospective, controlled 6-month trial. Fertil Steril 1987;47(3):402-8
69. Lam RW, et al. A controlled study of light therapy in women with late luteal phase dysphoric disorder. Psychiatry Res 1999;86:185-92
70. Parry, et al. Light therapy of late luteal phase dysphoric disorder: an extended study. Am J Psychiatry 1993;150:1417-9
71. Rose D: Diet, hormones and cancer. Ann Rev Publ Health 1993;14:1-7
72. Low Dog T. Integrative treatment for premenstrual syndrome. J Alt Therap Health Healing 2001;7:32-9
73. Rossignol AM, Bonnlander H. Caffeine-containing beverages, total fluid consumption and premenstrual syndrome. Am J Public Health 1990;80:1106-10.
74. Rossignol AM. Caffeine-containing beverages and premenstrual syndrome in young women. Am J Public Health 1985;75(11):1337-7
75. Rossignol AM, et al. Tea and premenstrual syndrome in the People’s Republic of China. Am J Public Health 1989;79:67-76
76. Sayegh R, et al: The effect of a carbohydrate-rich beverage on mood, appetite, and cognitive function in women with premenstrual syndrome. Obstet Gynecol 1995;86:520
77. Thys-Jacobs S, et al. Calcium carbonate and the premenstrual syndrome: Effects on premenstrual and menstrual symptoms. Am J Obstet Gynecol 1998;179:444-52
78. Ward MW, Holimon TD. Calcium treatment for premenstrual syndrome. Ann Pharmacother 1999;33:1356-8
79. Wyatt KM et al: Efficacy of vitamin B6 in the treatment of premenstrual syndrome: Systematic review. BMJ 1999;318:1375-81
80. Abraham GE, Lubran MM. Serum and red cell magnesium levels in patients with premenstrual tension. Am J Clin Nutr 1981;34:2364-6
81. Sherwood RA, et al. Magnesium and the premenstrual syndrome. Ann Clin Biochem 1986;23:667-70
82. Walker AF, et al. Magnesium supplementation alleviates premenstrual symptoms of fluid retention. J Womens Health 1998;7:1157-65
83. Proctor ML, Murphy PA. Herbal dietary therapies for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev. 2001;(3):CD002124
84. Takacs BE. Potassium: A new treatment for premenstrual syndrome. J. Orthomolec Med 1998;13:215-22
85. Steinberg S, et al. A placebo-controlled clinical trial of L-tryptophan in premenstrual dysphoria. Biol Psychiatry 1999;45:313-20
86. Bryant M, et al. Effect of consumption of soy isoflavones on behavioural, somatic and affective symptoms in women with premenstrual syndrome. Br J Nutr 2005;93:731-9
87. Chuong CJ, Dawson EB, Smith ER. Vitamin E levels in premenstrual syndrome. Am J Obstet Gynecol 1990;163:1591-5.
88. London RS, et al. The effect of alpha-tocopherol on premenstrual symptomatology: a double blind study. J Am Coll Nutr 1983;2(2):115-22
89. Sampalis F, et al. Evaluation of the effects of Neptune Krill Oil on the management of premenstrual syndrome and dysmenorrheal. Altern Med Rev 2003;8:171-9.
90. Hernandez-Reif M, et al. Premenstrual symptoms are relieved by massage therapy. J Psychosom Obstet Genaecol 2000;21:9-15
91. Oleson T. Randomized controlled study of premenstrual symptoms treated with ear, hand and foot reflexology. Obstet Gynecol 1993;82(6):906-11
92. Yu JN. Evaluation of clinical therapeutic effects and safety of acupuncture treatment for premenstrual syndrome. Zhongguo Zhen Jiu 2005;25(6):377-82
93. Yakir M, et al. Effects of homeopathic treatment in women with premenstrual syndrome: a pilot study. Br homeopathic J 2001;90:148-53
94. Stenchever MA, et al, eds. Comprehensive Gynecology, 4th ed. St Louis, MO:Mosby;2002.
95. Andersch B, Milsom I. An epidemiologic study of young women with dysmenorrheal. Am J Obstet Gynecol 1982;144:655-60.
96. Rainone F. Rakel D, ed. Dysmenorrhea. Integrative Medicine – Second Edition. Philadelphia, PA, Saunders Elsevier, 2007;56:613-7.
97. Velebil P, et al. Rate of hospitalization for gynecologic disorders among reproductive-age women in the United States. Obstet Gynecol 1995;86:764-9
98. Skidmore-Roth L. Mosby’s Handbook of Herbs and Natural Supplements – third Edition. St. Louis, MO, Elsevier Mosby, 2006:142-4
99. Kohama T, Herai K, Inoue M. Effect of French maritime pine bark extract on endometriosis as compared with leuprorelin acetate. J Reprod Med. 2007;52(8):703-8
100. Kohama T, et al. Analgesic efficacy of French maritime pine bark extract in dysmenorrheal: an open clinical trial. J Reprod Med. 2004;49(10):828-32
101. Harel Z, et al. Supplementation with omega-3 polyunsaturated fatty acids in the management of dysmenorrheal in adolescents. Am J Obstet Gynecol 1996; 174(4):1335-1338
102. Barnard ND, et al., Diet and sex-hormone binding globulin, dysmenorrhea, and premenstrual symptoms. Obstet Gynecol 2000;95:245-50
103. Deutch B, Jorgensen EB, Hansen JC. Menstrual discomfort in Danish women reduced by dietary supplements of omega-3 PUFA and B12 (fish or seal oil capsules). Nut Res 2000;20:621-31
104. Deutch B. Menstrual pain in Danish women correlated with low n-3 polyunsaturated fatty acid intake. Eur J Clin Nutr. 1995;49(7):508-16
105. Ziaei S, et al. A randomized placebo-controlled trial to determine the effect of vitamin E in the treatment of primary dysmenorrheal. BJOG 2001;108:1181-3
106. Ziaei S, Zakeri M, Kazemnejad A. A randomized controlled trial of vitamin E in the treatment of primary dysmenorrheal. BJOG 2005;112:466-9
107. Gokhale LB. Curative treatment of primary (spasmodic) dysmenorrhea. Ind J Med Res 1996;103:227-31
108. Proctor ML, Smith CA, Farquhar CM, Stones RW. Transcutaneous electrical nerve stimulation and acupuncture for primary dysmenorrhoea. Cochrane Database Syst Rev. 2002;(1):CD002123. Review
109. Society of Obstetricians and Gynaecologists of Canada. Primary dysmenorrhea consensus guidelines. JOGC 2005;169:1119-20
110. Zhu X et al. Chinese herbal medicine for primary dysmenorrheal. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD005288.DOI:10.1002/14651858.CD005288.pub2
111. Flower A, et al. Chinese herbal medicine for endometriosis. (Protocol) Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No.CD006568. DOI:10.1002/14651858.CD006568
112. Proctor ML, Farquhar C. Dysmenorrhoea. Clin Evid 2002;7:1639-53
113. Zhan C. Treatment of 32 cases of dysmenorrheal by puncturing hegu and sanyinjiao acupoints. J Trad Chin Med 1990;10:33-5
114. Wang XM: Observations of the therapeutic effects of acupuncture and moxibustion in 100 cases of dysmenorrheal. J Trad Chin Med 1987;7:15-7
115. Zhang YQ. A report of 49 cases of dysmenorrhea treated by acupuncture. J Trad Chin Med 1984;4:101-2
116. Helms JM. Acupuncture for the management of primary dysmenorrhea. Obstet Gynecol 1987;69:51-6
117. Proctor ML, et al. Transcutaneous electrical nerve stimulation and acupuncture for primary dysmenorrhea. Cochrane Database of Systematic Reviews 2002, Issue 1.Art No.: CD002123. DOI: 10.1002/14651858.CD002123.
118. Lurie S, et al. Age-related prevalence of sonographically confirmed uterine myomas. J Obstet Gynaecol 2005;25:42-4
119. Lethaby A, Vollenhoven B. Fibroids (uterine myomatosis, leiomyomas). Am Fam Physician 2005;71:1753-6
120. Day Baird D, et al. High cumulative incidence of uterine lieomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 2003;188(1):100-7
121. Evans P, Brunsell S. Uterine fibroid tumors: diagnosis and treatment. Am Fam Physician 2007;75(10)1503-1508.
122. Chez R. The etiology and treatment of uterine fibroids. Altern Ther 2002;8:32-33
123. Das UN. Is obesity and inflammatory condition? Nutrition 2001;17:953-66
124. Stewart EA, Nowak RA. Leiomyomata-related bleeding: A classic hypothesis updated for the molecular era. Human Reprd update 1996;2:295-306
125. Rakel D. Uterine Fibroids. Integrative Medicine – Second Edition. Philadelphia, PA, Saunders Elsevier, 2007;57:619-33.
126. Ostrezenski A. Benign uterine disorders. Gynecology Integrating Conventional, Complementary and Natural Alternative Therapy. Philadelphia, PA. Lippincott Williams & Wilkins, 2002;19:255-64.
127. Mehl-Madrona L. Complementary medicine treatment of uterine fibroids: a pilot study. Alternative Therapies in Health and Medicine 2002;8(2):34-6, 38-40, 42, 44-6
128. Kim DI, et al. Regulation of IGF-1 production and proliferation of human leiomyomal smooth muscle cells by Scutellaria barbata D. Done in vitro: isolation of flavonoids of apegenin and luteolin as acting compounds. Toxicol Appl Pharmocol 2005;205(3):213-24
129. Sang H. Clinical and experimental research into treatment of hysteromyoma with promoting qi flow and blood circulation, softening and resolving hard lump. Journal of Traditional Chinese Medicine 2004;24(4):274-9
130. Hull MG, et al. Population study of causes, treatment and outcome of infertility. BMJ (Clin Res Ed) 1985;291:1693-7
131. Rich-Edwards JW, et al. Physical activity, body mass index, and ovulatory disorder infertility. Epidemiology 2002;13:184-90
132. Chavarro Je, et al. Dietary fatty acid intakes and the risk of ovulatory infertility Am J Clin Nutr 2007;85:231-7
133. Chavarro JE, et al. A prospective study of dairy foods intake and anovulatory infertility. Hum Reprod 2007;22:1340-7
134. Schenker JG, Meirow D, Schenker E. stress and human reproduction. Eur J Otstet Gynecol Reprod Biol 1992;45:1-8
135. Eugster A, Vingerhoets AJ. Psychological aspects of in vitro fertilization: a review. Soc Sci Med 1999;48:575-89
136. Seibel MM, Taymore ML. Emotional aspects of infertility. Fertil Steril 1982;37:137-45
137. Domar AD, Seibel MM, Benson H. The mind/body program for infertility: a new behavioral treatment approach for women with infertility. Fertil Steril 1990;53:246-9
138. Cousineau TM, Domar AD. Psychological impact of infertility. Best Pract Res Clin Obstet Gynaecol 2007;21(2):293-308
139. Wuttke W, et al. Chaste tree (Vitex agnus-castus) - Pharmacology and clinical indications. Phytomed 2003;10:348-57
140. Gerhard IL, et al. Mastodynon for female sterility. Forsch Komplementarmed 1998;5:272-8
141. Westphal LM, et al. A nutritional supplement for improving fertility in women. J Reprod med 2004;49:289-93
142. Henmi H, et al. Effects of ascorbic acid supplementation on serum progesterone levels in patients with luteal phase defect. Fertil Steril 2003;80:459-61.
143. Domar AS, Seibel MM, Benson H. The mind/body program for infertility: a new behavioral treatment approach for women with infertility. Fertil Sterl 1990;53:246-9
144. Burns LH. Psychiatric aspects of infertility and infertility treatments. Psychiatr Clin North Am 2007;30(4):689-716
145. Gravitz MA. Hypnosis in the treatment of functional infertility. Am J Clin Hypn 1995;38:22-26
146. Smith WH. Hypnosis in the treatment of anxiety. Bull Menninger Clin 1990;54:209-216
147. Chavarro JE. Diet and lifestyle in the prevention of ovulatory disorder infertility. Obstet Gynecol 2007;110(5)1050-8
148. Wurn BF, et al. Treating female infertility and improving IVF pregnancy rates with a manual physical therapy technique. Medscape General medicine. 2004;6(2):51
149. Stener-Victorin E, Waldenström U, Andersson SA, Wikland M. Reduction of blood flow impedance in the uterine arteries of infertile women with electro-acupuncture. Hum Reprod. 1996 Jun;11(6):1314-7.
150. Ferin M, Van de Wiele RL. Endogenous opioid peptides and the control of the menstrual cycle. Eur J Obstet Gynecol Repro Biol 1984;10:365-73
151. Anderson BJ. In vitro fertilization and acupuncture: clinical efficacy and mechanistic basis. Altern Ther Health Med 2007;13(3):38-48
152. Manheimer E, et al. Effects of acupuncture on rates of pregnancy and live birth among women undergoing in vitro fertilization: systematic review and meta-analysis. BMJ 2008; doi:1136/bmj.39471.430451.BE
153. Smith C, Coyle M, Norman RJ. Influence of acupuncture stimulation on pregnancy rates for women undergoing embryo transfer. Fertil Steril. 2006;85(5):1352-8
154. Dietrle S, et al. Effect of acupuncture on the outcome of in vitro fertilization and intracytoplasmic sperm injection: a randomized, prospective, controlled clinical study. Fertil Sterl 2006;85(5):1347-51
155. Westergaard LG, et al. Acupuncture on the day of embryo transfer significantly improves reproductive outcome in infertile women: a prospective, randomized trial. Fertil Steril 2006;85(5):1341-6
156. Paulus WE, et al. Influence of acupuncture on the pregnancy rate in patients who undergo assisted reproduction therapy. Fert Steril 2002;77:721-4
157. Klibanski, et al. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285:785-95
158. World Health Organization. Assessment of fracture risks and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 843. Geneva: WHO; 1994
159. Pols HAP. Epidemiological aspects of osteoporosis in men and women [abstract]. Program and abstracts of The 1st Joint Meeting of the International Bone and Mineral Society and the European calcified Tissue Society; June 5-10, 2001; Madrid, Spain. Bone. 2001;28suppl):S67.
160. National Osteoporosis Foundation. America’s bone health: The state of osteoporosis and low bone mass in our nation. Washington, DC: National Osteoporosis Foundation; 2002
161. Cooper C. Global assessment of fracture risk. Osteoporos Int. 2000:11(suppl2):S44
162. Gabriel SE, et al. direct medical costs attributable to osteoporotic fractures. Osteoporos Int 2002;13:323-30
163. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996;312:1254-9
164. Rakel D. Osteoporosis. Integrative Medicine – Second Edition. Philadelphia, PA, Saunders Elsevier, 2007;417-27.
165. Potter SM, et al. soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 1998;68(6 Suppl):1375S-9S
166. Xianglan Z, et al. Prospective cohort study of soy food consumption and risk of bone fracture among postmenopausal women. Arch Intern Med 2005;165:1890-5
167. Pocock NA, et al. Mechanical load and the skeleton: the interaction of regional muscle strength, physical fitness and weight with bone mass. J Bone Miner Res 1989;4:441-8
168. Gillespie LD, et al. Interventions for preventing falls in elderly people. Cochrane Database Syst Rev 2001 (3). CD000340
169. Verhagen AP, et al. The efficacy of Tai Chi chuan in older adults: a systematic review. Fam Pract 2004;21:107-13
170. Woo J, et al. A randomised controlled trial of Tai Chi and resistance exercise on bone health, muscle strength and balance in community-living elderly people. Age Ageing. 2007;36(3)262-8
171. Chan K, et al. A randomized, prospective study of the effects of Tai Chi Chun exercise on bone mineral density in postmenopausal women. Arch Phys Med Rehabil. 2004;85(5):717-22
172. Wayne PM. The effects of Tai Chi on bone mineral density in postmenopausal women: a systematic review. Arch Phys Med Rehabil 2007;88(5):673-80
173. Lee MS, et al. Tai chi for osteoporosis: a systematic review. Osteoporos Int. 2008;19(2):139-46
174.Voukelatos A. A randomized, controlled trial of tai chi for the prevention of falls: the Central Sydney tai chi trial. J Am Geriatr Soc. 2007;55(8):1185-91
175. Li F, et al. Tai chi and fall reductions in older adults: a randomized controlled trial. J Geronto A Biol Sci Med Sci. 2005;60(2):187-94
176. Rizzoli R, et al. Protein intake and bone disorders in the elderly. Joint Bone Spine 2001;68:383-92
177. Kerstetter JE, O’Brien KO, Insogna KL. Low protein intake: the impact on calcium and bone homeostasis in humans. J Nutr 2003;133:855S-861S
178. Barzel US, Massey, LK. Excess dietary protein can adversely affect bone. J Nutr 1998;128:1051-3
179. Barzel US. Dietary patterns and blood pressure [letter]. N Engl J Med. 1997;337:637
180. Krieger NS, Sesler NE, Bushnsky Da. Acidosis inhibits osteoblastic and osteoclastic activity in vitro. Am J Physiol 1992;262:F442-8
181. Bushinsky DA. Net calcium efflux from live bone during chronic metabolic, but not respiratory acidosis
182. Lemann J Jr. Relationship between urinary calcium and net acid excretion as determined by dietary protein and potassium: a review. Nephron 1999;81:18-25
183. Remer T. Influence of diet on acid-base balance. Semin Dial 2000;13:221-6
184. Buclin T, et al. Diet acids and alkalis influence calcium retention in bone. Osteoporos Int 2001;12:493-9
185. Frassetto LA, et al Worldwide incidence of hip fracture in elderly women: Relation to consumption of animal and vegetable foods. J Gerontol A Biol Sci Med Sci 2000;55:M585-92
186. Weikert C, et al. The relation between dietary protein, calcium and bone health in women: results from the EPIC-Potsdam Cohort. Ann Nutr Metab 2005;49:312-8
187. Sellmeyer DE, et al. A high ratio of animal to vegetable protein increases the rate of bone loss and the risk of fracture in postmenopausal women. Am J Clin Nutr 2001;73:118-22
188. New SA, et al. Dietary influences on bone mass and bone metabolism: further evidence of a positive link between fruit and vegetable consumption and bone health. Am J clin Nutr 2000;71:142-51
189. Scheiber MD, Rebar RW. Isoflavones and postmenopausal bone health: a viable alternative to estrogen therapy? Menopause 1999;6:233-41
190. Rude RK, et al. Magnesium deficiency induces bone loss in the rat. Miner Electrolyte Metab 1998;24:314-20
191. Lanou AJ, Berkow SE, Barnard ND. Calcium, dairy products, and bone health in children and young adults: a re-evaluation of the evidence. Pediatrics 2005;115:736-43
192. Witzenberg T, et al. Effects of calcium supplementation on bone density in healthy children: meta-analysis of randomized controlled trials. BMJ 2006 doi:10.1136/bmj.38950.561400.55
193. Shea B, et al. Calcium supplementation on bone loss in postmenopausal women. Cochrane Database of Systematic Reviews 2003, issue 4. Art. No.: CD004526. DOI: 10.1002/14651858.CD004526.pub3
194. Tang BM, et al. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 2007;370(9588):657-66
195. Holick MF, et al. Prevalence of vitamin D inadequacy among postmenopausal women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005;90:3215-24
196. Avenell A, et al. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database of Systematic Reviews 1996, Issue 4. Art. No.: CD000227. DOI: 10.1002/14651858.CD000227.pub2. Last update 2005
197. Bischoff-Ferrari HA, et al. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005;293(18):2257-64
198. Venning G. Recent developments in vitamin D deficiency and muscle weakness among elderly people. BMJ 2005;330:524-6
199. Hall SL, Greendale GA. The relation of dietary vitamin C intake to bone mineral density: results from the PEPI study. Calcif Tissue Int. 1998;63(3):183-9
200. Adams J, Pepping J. Vitamin K in the treatment and prevention of osteoporosis and arterial calcification. Am J Health-Syst Pharm 2005;62(15):1574-81
201. Feskanish D, et al. Vitamin K intake and hip fractures in women: a prospective study. Am J Clin Nutr. 1999;69:74-9
202. Shiraki M, et al. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J None Miner Res. 2000;15:515-21
203. Knapen MH, Schurgers LJ, Vermeer C. Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporos Int. 2007 Jul;18(7):963-72.
204. Alexandersen P, et al. Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial. JAMA 2001;285(11)1482-8
205. Zofkova I, Bahbouh R, hill M. The pathophysiologic implications of circulating androgens on bone mineral density in a normal female population. Steroids 2000;65:857-61
206. Jankowski CM, et al. Effects of dehydorepiandrosterone replacement therapy on bone mineral density in older adults: a randomized, controlled trial. J Clin Endorinol Metab 2006;91:2986-93
207. Arnold JT, Blacman MR. Does DHEA exert direct effects on androgen and estrogen receptors, and does it promote or prevent prostate cancer? Endocrinology. 2005; 146(11):4565-4567.
208. Tworoger SS, Missmer SA, Eliassen AH, Spiegelman D, Folkerd E, Dowsett M, Barbieri RL, Hankinson SE. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women. Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):967-71
209. Weiss LA, Barrett-Connor E, von Muhlen D. Ratio of omega-6 to omega-3 fatty acids and bone mineral density in older adults. The Rancho Bernardo Study. Am J Clin Nutr 2005;81:934-8
210. Whiting SJ, Vatanparast H. Nutritional interventions in osteoporosis. Geriatrics Aging 2005;8(9):14-20
211. Tinetti ME, et al. A multifactorial intervention to reduce the risk of falling among elderly people living in the community. NEJM 1994;331:821-7
212. Xu YL. [Effects of acupuncture plus acupoint sticking on bone mass density and pain in the patient of primary osteoporosis] Abstract. Zhongguo Zhen Jiu 2006;26(2)87-90
213. Abrams P, et al. The standardization of terminology of lower urinary tract function. Scand J Urol Nephrol 1988 (suppl);114:5-19
214. National Institutes of Health. Prevention of fecal and urinary incontinence in adults. State-of-the-Science Conference Statement 2007.
215. Burgio KL, et al. Treatment seeking for urinary incontinence in adults. J Am Geriatr Soc 1994;42:208-12
216. Hunskaar S, et al. Epidemiology and natural history of urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2000;11:301-19
217. Wilson L, et al. Annual direct cost of urinary incontinence. Obstet Gynecol 2001;98:398-406
218. ACOG. Urinary Incontinence in Women. ACOG Practice Bulletin 2005, Number 63
219. Jepson RG, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database of systematic Reviews 1998, Issue 4. Art. No.: CD001321. DOI: 10.1002/14651858. CD001321.pub4
220. Skidmore-Roth L. Mosby’s Handbook of Herbs and Natural Supplements, 3nd Edition. St. Louis, MO, Elsevier Mosby, 2006:358-61
221. Li Z, et al. Cranberry does not affect prothrombin time in male subjects on warfarin. J Am Diet Assoc 2006;106(12):2057-61
222. Wilt T, Ishani A. MacDonald R. Serenoa repens for benign prostatic hyperplasia. Cochrane Databse of Systematic Reviews 1999, Issue 1.Art. No.: CD001423. DOI: 10.1002/14651858.CD001423
223. Skidmore-Roth, ed. Mosby’s Handbook of Herbs & Natural Supplements, 3nd Edition. St. Louis, MO, Elsevier Mosby, 2006:919-23
224. Hernon CD, Joseph DB. Urinary incontinence. Pediatr Clinic North Am 2006;53(3):363-77,vi
225. Moldwin RM, et al. Rational approaches to the treatment of patients with interstitial cystitis. Urology 2007;69(4 suppl):73-81
226. Bump RC, McClish DK. Cigarette smoking and urinary incontinence in women. Am J Obstet Gynecol 1992;167:1213-8
227. Tampakoudis P, et al. Cigarette smoking and urinary incontinence in women – a new calculative method of estimating the exposure to smoke. Eur J Obstet Gynecol Reprod Biol 1995;63:27-30
228. Hunskaar S, et al. Epidemiology of urinary (UI) and faecal (FI) incontinence and pelvic organ prolapse. In Abrams P, ed. Incontinence: 3nd International consultation, Plymouth, UK: Health Publications;2005:255-312
229. Newman DK. Urinary incontinence and overactive bladder: A focus on behavioral interventions. Topics in Advanced Practice Nursing eJournal 2001;1(1)
230. Bump RC, McClish DM. Cigarette smoking and pure genuine stress incontinence of urine. A comparison of risk factors and determinants between smokers and nonsmokers. Am J Obstet Gynecol. 1994;170:579-82
231. Brown JS, et al. Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Obstet Gynecol 1999;94:66-70
232. Stewart WF, et al. Prevalence and burden of overactive bladder in the United States. World J Urol 2003;20:327-36
233. Wallace SA, et al. Bladder training for urinary incontinence in adults. Cochrane Database of Systematic Reviews 2000, Issue 1. Art. No.:CD001308. DOI: 10.1002/14651858.CD001308.pub2
234. Ostaszkiewicz J, Chestney T, Roe B. Habit retraining for the management of urinary incontinence in adults. Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No.:CD002801.DOI: 10.1002/14651858.CD002801.pub2
235. Weatherall. Biofeedback or pelvic floor muscle exercises for female genuine stress incontinence: a meta-analysis of trials identified in a systematic review. BJU Int 1999;83(9):1015-6
236. Burgio KL, et al. Behavioral training with and without biofeedback in the treatment of urge incontinence in older women: A randomized controlled trial. JAMA 2002;288(18):2293-2299
237. Freeman RM, Baxby K. Hypnotherapy for incontinence caused by the unstable detrusor. BMJ 1982;284:1831-4
238. Eustice S, Roe B, Paterson J. Prompted voiding for the management of urinary incontinence in adults. Cochrane Database of Systematic Reviews 2000, Issue 2. Art. No.:CD002113. DOI:10.1002/14651858.CD02113
239. Shaikh S, et al. Mechanical devices for urinary incontinence in women. Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD001756. DOI: 10.1002/14651858. CD001756.pub4
240. Kegel AH. Progressive resistance exercise in the functional restoration of the perineal muscles. Am J Obstet Gynecol 1948;56:238
241. Bo K, Talseth T, Holme I. Single blind, randomised controlled trial of pelvic floor exercises, electrical stimulation, vaginal cones, and no treatment in management of genuine stress incontinence in women. BMJ 1999;318:487-93
242. Hay-Smith EJC, Dumoulin C. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD005654. DOI: 10.1002/14651858.CD005654
243. Sand PK, et al. Pelvic floor electrical stimulation in the treatment of genuine stress incontinence: a multi-center, placebo-controlled trial. Am J Obstet Gynecol 1995;173:72-9.
244. Yasuda K, Yamanishi T. critical evaluation of electro-stimulation for management of female urinary incontinence. Curr Opin Obstet Gynecol 1999;11(5): 503-7
245. Goode PS, et al. Effect of behavioral training with or without pelvic floor electrical stimulation on stress incontinence in women: A randomized controlled trial.
246. Herbison P, Mantle J, Dean N. Weighted vaginal cones for urinary incontinence. Cochrane Database of Systematic Reviews 2000, Issue 2. Art. No.: CD002114. DOI:10.1002/14651858.CD002114
247. Bergstrom K, et al. Improvement of urge and mixed-type incontinence after acupuncture treatment among elderly women – a pilot study. J Auton Ner Syst. 2000;79(2-3):173-80
248. Emmons S, Otto L. Acupuncture for overactive bladder: A randomized controlled trial. Obstet Gynecol 2005;106(1):138-43
249. Thomas LH, et al. Treatment of urinary incontinence after stroke in adults. Cochrane Database of Systematic Reviews 2005, issue 3. Art. No.: CD004462. DOI: 10.1002/14651858.CD004462.pub3
250. Sung LM, Jiaqi W. Acupuncture for urinary incontinence in adults without neurological disease. (Protocol) Cochrane Database of Systematic Reviews 2006, Issue r. Art. No.: CD006235. DOI: 10:1002/14651858.CD006235
| The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. |